Can Blood Glucose Levels During the Perioperative Period Identify a Population at Risk for Hyperglycemia?

Hyperglycemia Clinical Trial

Official title:

Can Blood Glucose Levels During the Perioperative Period Identify a Population at Risk for Hyperglycemia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00468494
• Other study ID #: 0120060208
• Status: Completed
• Phase: N/A
• First received: April 30, 2007
• Last updated: January 24, 2013
• Start date: September 2006
• Est. completion date: June 2010

Study information

• Verified date: January 2013
• Source: Rutgers, The State University of New Jersey
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

Surgery performed during general anesthesia induces a stress effect on the body. Our plan is to identify population at risk of hyperglycemia during perioperative period.

Description:

This is a prospective study to define the relationship between time profile of glucose control before, during and after surgery with patient variables, surgical variables and anesthetic variables. Serum glucose levels will be measured preoperatively and then at 30 minute intervals during surgery. Pain score, pain medication and glucose levels will be measured in the post anesthesia recovery room. Subjects will be contacted 2 weeks following the date of surgery to determine the incidence of postoperative complications.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 308
• Est. completion date: June 2010
• Est. primary completion date: June 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Elective surgery

• 18-80 years of age

Exclusion Criteria:

• Known diabetics

• Pregnant patients

• Cardiac surgery patients

• Liver transplant patients

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• General Anesthesia
• Hyperglycemia

Locations

Country	Name	City	State
United States	University of Medicine & Dentistry of New Jersey	Newark	New Jersey

Sponsors (1)

Lead Sponsor	Collaborator
University of Medicine and Dentistry of New Jersey

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	glucose level at specific points		Intraoperatively and in the PACU	No
Secondary	pt telephoned to assess for complications		within 2 weeks of surgery	No